DE3327705A1 - Mutterkornalkaloide, ihre herstellung und verwendung - Google Patents
Mutterkornalkaloide, ihre herstellung und verwendungInfo
- Publication number
- DE3327705A1 DE3327705A1 DE19833327705 DE3327705A DE3327705A1 DE 3327705 A1 DE3327705 A1 DE 3327705A1 DE 19833327705 DE19833327705 DE 19833327705 DE 3327705 A DE3327705 A DE 3327705A DE 3327705 A1 DE3327705 A1 DE 3327705A1
- Authority
- DE
- Germany
- Prior art keywords
- formula
- compounds
- acid addition
- compound
- free base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH4772/82A CH649998A5 (de) | 1982-08-09 | 1982-08-09 | Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff. |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3327705A1 true DE3327705A1 (de) | 1984-02-09 |
Family
ID=4282273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19833327705 Withdrawn DE3327705A1 (de) | 1982-08-09 | 1983-08-01 | Mutterkornalkaloide, ihre herstellung und verwendung |
Country Status (23)
Country | Link |
---|---|
JP (1) | JPS5948480A (da) |
AT (1) | AT383125B (da) |
AU (1) | AU563736B2 (da) |
BE (1) | BE897473A (da) |
CA (1) | CA1215972A (da) |
CH (1) | CH649998A5 (da) |
DE (1) | DE3327705A1 (da) |
DK (1) | DK361983A (da) |
ES (1) | ES8502992A1 (da) |
FI (1) | FI73679C (da) |
FR (1) | FR2531433B1 (da) |
GB (1) | GB2125041B (da) |
GR (1) | GR78923B (da) |
HU (1) | HU187600B (da) |
IL (1) | IL69450A (da) |
IT (1) | IT1168961B (da) |
MY (1) | MY8700166A (da) |
NL (1) | NL8302776A (da) |
NZ (1) | NZ205181A (da) |
PH (1) | PH20385A (da) |
PT (1) | PT77168B (da) |
SE (1) | SE8304315L (da) |
ZA (1) | ZA835850B (da) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0185491A1 (en) * | 1984-12-10 | 1986-06-25 | Eli Lilly And Company | Ergoline derivatives |
DE10212564B4 (de) * | 2002-03-12 | 2007-04-19 | Neurobiotec Gmbh | 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU193782B (en) * | 1985-06-21 | 1987-11-30 | Richter Gedeon Vegyeszet | Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof |
FR2589734B1 (fr) * | 1985-11-13 | 1988-09-02 | Roussel Uclaf | Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique |
US4798834A (en) * | 1987-08-31 | 1989-01-17 | Eli Lilly And Company | Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement |
DE3913756A1 (de) * | 1989-04-21 | 1990-10-25 | Schering Ag | 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE41533B1 (en) * | 1974-03-14 | 1980-01-30 | Sandoz Ltd | Thiomethyl ergolene derivatives |
US3901894A (en) * | 1974-06-06 | 1975-08-26 | Lilly Co Eli | 8-thiomethylergolines |
US3959288A (en) * | 1974-12-13 | 1976-05-25 | Eli Lilly And Company | 8-Oxymethylergolines and process therefor |
US4166182A (en) * | 1978-02-08 | 1979-08-28 | Eli Lilly And Company | 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds |
US4382940A (en) * | 1979-12-06 | 1983-05-10 | Farmitalia Carlo Erba S.P.A. | Ercoline derivatives and therapeutic compositions having CNS affecting activity |
-
1982
- 1982-08-09 CH CH4772/82A patent/CH649998A5/de not_active IP Right Cessation
-
1983
- 1983-08-01 DE DE19833327705 patent/DE3327705A1/de not_active Withdrawn
- 1983-08-02 FI FI832789A patent/FI73679C/fi not_active IP Right Cessation
- 1983-08-04 FR FR8313018A patent/FR2531433B1/fr not_active Expired
- 1983-08-05 BE BE1/10847A patent/BE897473A/fr not_active IP Right Cessation
- 1983-08-05 GB GB08321222A patent/GB2125041B/en not_active Expired
- 1983-08-05 NL NL8302776A patent/NL8302776A/nl not_active Application Discontinuation
- 1983-08-08 SE SE8304315A patent/SE8304315L/xx not_active Application Discontinuation
- 1983-08-08 IL IL69450A patent/IL69450A/xx unknown
- 1983-08-08 HU HU832798A patent/HU187600B/hu unknown
- 1983-08-08 DK DK361983A patent/DK361983A/da unknown
- 1983-08-08 PT PT77168A patent/PT77168B/pt unknown
- 1983-08-08 ES ES524815A patent/ES8502992A1/es not_active Expired
- 1983-08-08 CA CA000434064A patent/CA1215972A/en not_active Expired
- 1983-08-08 NZ NZ205181A patent/NZ205181A/en unknown
- 1983-08-08 GR GR72165A patent/GR78923B/el unknown
- 1983-08-08 AU AU17672/83A patent/AU563736B2/en not_active Expired - Fee Related
- 1983-08-08 JP JP58144843A patent/JPS5948480A/ja active Pending
- 1983-08-08 AT AT0286383A patent/AT383125B/de not_active IP Right Cessation
- 1983-08-09 ZA ZA835850A patent/ZA835850B/xx unknown
- 1983-08-09 PH PH29378A patent/PH20385A/en unknown
- 1983-08-09 IT IT22490/83A patent/IT1168961B/it active
-
1987
- 1987-12-30 MY MY166/87A patent/MY8700166A/xx unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0185491A1 (en) * | 1984-12-10 | 1986-06-25 | Eli Lilly And Company | Ergoline derivatives |
DE10212564B4 (de) * | 2002-03-12 | 2007-04-19 | Neurobiotec Gmbh | 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne |
Also Published As
Publication number | Publication date |
---|---|
BE897473A (fr) | 1984-02-06 |
DK361983A (da) | 1984-02-10 |
DK361983D0 (da) | 1983-08-08 |
AU1767283A (en) | 1984-02-16 |
FI73679B (fi) | 1987-07-31 |
IT8322490A0 (it) | 1983-08-09 |
ZA835850B (en) | 1985-03-27 |
SE8304315L (sv) | 1984-02-10 |
CH649998A5 (de) | 1985-06-28 |
IT1168961B (it) | 1987-05-20 |
IL69450A0 (en) | 1983-11-30 |
HU187600B (en) | 1986-01-28 |
PT77168A (en) | 1983-09-01 |
FI832789A (fi) | 1984-02-10 |
MY8700166A (en) | 1987-12-31 |
PH20385A (en) | 1986-12-08 |
ES524815A0 (es) | 1985-02-01 |
ATA286383A (de) | 1986-10-15 |
ES8502992A1 (es) | 1985-02-01 |
SE8304315D0 (sv) | 1983-08-08 |
CA1215972A (en) | 1986-12-30 |
NZ205181A (en) | 1986-07-11 |
FR2531433B1 (fr) | 1985-10-18 |
FI832789A0 (fi) | 1983-08-02 |
GB2125041B (en) | 1986-04-23 |
FI73679C (fi) | 1987-11-09 |
GR78923B (da) | 1984-10-02 |
GB8321222D0 (en) | 1983-09-07 |
FR2531433A1 (fr) | 1984-02-10 |
NL8302776A (nl) | 1984-03-01 |
AU563736B2 (en) | 1987-07-23 |
JPS5948480A (ja) | 1984-03-19 |
IL69450A (en) | 1986-10-31 |
GB2125041A (en) | 1984-02-29 |
AT383125B (de) | 1987-05-25 |
PT77168B (en) | 1986-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3010544A1 (de) | 1h-pyrrolo eckige klammer auf 2,1-c eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepin- 2-acrylsaeureamid-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
EP2060569A1 (de) | 3-[(2-{[4-Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat-Hemihydrat und dessen Verwendung als Arzneimittel | |
DE2300107C2 (de) | Vitamin A-Säureanilid-4-carbonsäureäthylester, Verfahren zu seiner Herstellung und diesen enthaltende Zubereitungen | |
EP0044940B1 (de) | Amino-desoxy-1.4; 3.6-dianhydro-hexit-nitrate, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung | |
EP0189370A2 (de) | Spiro-dioxolane, -dithiolane und -oxothiolane | |
DE2602643A1 (de) | 1,2-benzisothiazolinone-3, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel | |
DE69224507T2 (de) | Beta-Oxo-Beta-Benzenepropanthioamidderivate | |
CH625790A5 (da) | ||
DE69102477T2 (de) | 3-Aminochroman-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. | |
DE3327705A1 (de) | Mutterkornalkaloide, ihre herstellung und verwendung | |
DE3730748A1 (de) | Neue polyoxygenierte labdanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE2523103A1 (de) | Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben | |
EP0285681B1 (de) | Verfahren zur Herstellung von Nitroethenderivaten | |
EP0011596B1 (de) | Neue 2-(alpha-Phenoxy-alkyl)-imidazoline und ihre Salze, deren Herstellung und Verwendung sowie sie enthaltende Mittel zur Bekämpfung von pflanzenschädlichen und tierparasitären Milben | |
DE2535599C2 (de) | Substituierte Zimtsäureamide, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten | |
DE2427272C3 (de) | 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum | |
CH617197A5 (da) | ||
CH657366A5 (en) | Ergot alkaloids, their preparation and use | |
DE2713586A1 (de) | Neue organische verbindungen, verfahren zu ihrer herstellung und ihre verwendung | |
DE2925803A1 (de) | Neue cystaminderivate und verfahren zu deren herstellung | |
DE2716172C2 (de) | Bis(6-[(hexahydro-1H-azepin-1-yl)-methylenamino]-penicillanoyloxy)-methan, seine Herstellung und dieses enthaltendes Arzneimittel | |
DE2520131A1 (de) | Stickstoffhaltige polycyclische verbindungen und verfahren zu deren herstellung | |
DE1302649B (de) | Sulfensaeurederivate, ein verfahren zu deren herstellung und deren verwendung | |
DE2755727A1 (de) | Derivate des 1,2,4-triazolidin- 2,5-dions, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
DE2656227C2 (de) | Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8139 | Disposal/non-payment of the annual fee |